There were 1,678 press releases posted in the last 24 hours and 413,771 in the last 365 days.

Awareness About Immunization Benefits Is A Key Factor In The Vaccines Market Growth

Vaccines Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

Vaccines Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Vaccines Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON , UK, January 27, 2022 /EINPresswire.com/ -- Rising awareness on immunization and vaccination benefits in emerging markets is consistently driving the global vaccines market growth. World Health Organization (WHO) is taking initiatives to increase awareness of immunization through global vaccine action plan (GVAP) and global Immunization vision and strategy (GIVS). They aim to strengthen routine immunization, control morbidity and mortality from vaccine preventable diseases and help countries to immunize more people with a greater range of vaccines. The Organization accomplishes this work through its biological program, the WHO Collaborating Centers, and the WHO Expert Committee on Biological Standardization (ECBS).

The global vaccines market size is expected to grow from $92.70 billion in 2021 to $105.20 billion in 2022 at a compound annual growth rate (CAGR) of 13.5%. The slow decline is mainly due to the outbreak of COVID-19 that has led to deferment of immunocompromised treatments. The market is expected to reach $290.67 billion in 2026 at a CAGR of 28.9%.

Read More On The Global Vaccines Market Report:
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

The global vaccines market has been witnessing multiple strategic initiatives and mergers and acquisitions in the recent years. Top companies in the market are strategically acquiring start-ups and mid-sized companies to broaden products and services. For instance, in February 2019, Bharat Biotech acquired Chiron Behring Vaccines, a clinical biotechnology company, one of the leading manufacturers of rabies vaccines across the globe. Similarly, in September 2021, Sanofi, a France based healthcare company, acquired Translate Bio, an mRNA therapeutics company developing potentially transformative medicines to treat diseases caused by protein or gene dysfunction, for a deal amount of $3.2 billion to develop mRNA vaccines. Companies in the industry are increasingly realigning their portfolios and pursuing profitable inorganic growth opportunities. Additionally, M&A interest is also being fueled by stronger corporate balance sheets, liquid debt markets, and continued favorable interest rates globally.

Major players covered in the global vaccines industry are AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck, Pfizer, Sanofi Pasteur, Abbott, Astellas Pharma, Bavarian Nordic, CSL Limited, Daiichi Sankyo Company, Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India, Takeda Pharmaceutical Co. Ltd., Biological E Limited, BiondVax Pharmaceuticals Ltd, Bristol-Myers Squibb, Inovio Pharmaceuticals Inc., Madison Vaccines Incorporated, NOVARTIS AG, Novavax Inc., Panacea Biotec, Sinovac Biotech Ltd., Valneva SE, and VBI Vaccine Inc.

North America was the largest region in the vaccine market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
TBRC’s global vaccines market segmentation is divided by type into anti-infective vaccines, autoimmunity, others (cancer and others), by technology into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, by route of administration into intramuscular (IM), subcutaneous (SC), oral, others, by valence into monovalent, multivalent, by distribution channel into institutional sale, hospital pharmacies, retail pharmacies.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides a vaccines market overview, forecast vaccines market size and vaccines market growth for the whole market, vaccines market segments, geographies, vaccines market trends, vaccines market drivers, vaccines market restraints, leading competitors’ revenues, profiles, and vaccines market market shares.

Request For A Sample Of The Global Vaccines Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2556&type=smp

Not what you were looking for? Here is a list of similar reports by The Business Research Company:
DTP Vaccines Global Market Report 2021 - By Product Type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End User (Hospitals, Clinics, Vaccination Centers), COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/dtp-vaccines-global-market-report-2020-30-covid-19-growth-and-change

Cancer Vaccines Global Market Report 2021 - By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat), By End-User (Cancer Treatment Centers, Research Institutes), COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/cancer-vaccines-global-market-report-2020-30-covid-19-growth-and-change

Biologics Global Market Report 2021 - By Type (Monoclonal Antibodies (MABs), Therapeutic Proteins, Vaccines), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/biologics-global-market-report

About The Business Research Company

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn